FDA approves Emrosi for rosacea in adults
The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...
Intercept Receives Complete Response Letter from FDA Addressing OCALIVA supplemental New Drug Application (sNDA)
The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...
Business Insider1d
Philips receives FDA 510(k) clearance for Spectral CT 7500 RT
Royal Philips (PHG) announced a major advance in radiation oncology with 510(k) clearance from the US Food and Drug Administration for its new detector-based spectral computed tomography radiotherapy ...
FDA Regulatory Compliance for Drug and Biotech Product Training Course (ONLINE EVENT: December 2-3, 2024/ON-DEMAND)
The "FDA Regulatory Compliance for Drug and Biotech Product Training Course" training has been added to ResearchAndMarkets.com's offering. This course will benefit professionals involved in working ...
BBC5d
Nurse’s death linked to approved weight-loss drug
The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the ...